{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-073072","form_type":"8-K","ticker":"PFSA","cik":"0001859807","company_name":"Profusa, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.413816+00:00","generated_at":"2026-05-17T18:22:24.098336+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"Profusa strategy update: $100M ELOC secured, EU launch Q1 2026, FDA submission mid-2026","bullets":["Became public on Nasdaq July 14, 2025; strategy focused on five pillars including revenue growth and AI infrastructure.","First distributor partner in Spain for Lumee tissue oxygen platform; EU commercial launch targeted Q1 2026.","U.S. FDA submission planned mid-2026 with U.S. commercialization anticipated mid-2027 for oxygen monitoring.","Continuous glucose monitoring: human validation data expected in peer-reviewed journal; pivotal studies later 2026.","Secured $100M ELOC facility and implementing digital investment treasury plan to support growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-073072","json":"https://secwatch.observer/filing/0001213900-25-073072.json","markdown":"https://secwatch.observer/filing/0001213900-25-073072.md","text":"https://secwatch.observer/filing/0001213900-25-073072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859807/000121390025073072/0001213900-25-073072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859807/000121390025073072/ea0252144-8k_profusa.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:22:24.098336+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}